Arcturus Therapeutics Funding & Investors
Arcturus Therapeutics Holdings Inc. operates as a holding company. The company, through its subsidiaries, focuses on RNA therapeutics for the treatment of diseases. Arcturus Therapeutics Holdings serves patients in the United States.
arcturusrx.comTotal Amount Raised: $489,580,064
Arcturus Therapeutics Funding Rounds
Grant
$9,000,000
Grant Investors
Cystic Fibrosis FoundationGrant
$115,000,000
Grant Investors
Government of JapanGrant
$63,200,000
Grant Investors
Biomedical Advanced Research and Development AuthoritySeries A
$5,000,000
Seed
$1,300,000
Seed
$580,001
Grant
$15,000,000
Post Ipo Equity
$200,000,000
Post Ipo Equity
$80,500,049
Funding info provided by Diffbot.